Search - tctmd.com

Displaying 481 - 500 of 546

Sort: Relevancy | Date

News Daily News

Un Registro Coreano Revela un Mayor Uso de PCI en el Manejo de la Enfermedad de Tronco Coronario Izdo. Con Mejores Resultados

L.A. McKeown

April 03, 2015

News Daily News

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

L.A. McKeown

April 03, 2015

News Daily News

‘Value’ of PCI Varies Widely Across VA Hospitals

Yael L. Maxwell

January 28, 2015

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

Presentation TCT 2014

Special Lecture: Predicting the EXCEL Results from the SYNTAX Score II

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

News Daily News

欧洲学会发布更新后的CAD血运重建指南

L.A. McKeown

September 11, 2014

News Daily News

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

L.A. McKeown

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Daily News

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Todd Neale

July 30, 2014

News Daily News

Meta Análisis: El Sexo del Paciente Influye en la Respuesta del Abordaje Invasivo Rutinario en el Manejo de Cuadros de SCASEST

Todd Neale

July 30, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

Readmissions Higher with PCI vs CABG for Left Main Disease

March 14, 2014

News Daily News

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

March 14, 2014

Presentation CTO 2014

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Presenter: Gregg W. Stone

March 01, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation TCT 2013

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Presenter: Gregg Stone

October 28, 2013

News Daily News

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

July 24, 2013

Advertisement

Un Registro Coreano Revela un Mayor Uso de PCI en el Manejo de la Enfermedad de Tronco Coronario Izdo. Con Mejores Resultados

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

‘Value’ of PCI Varies Widely Across VA Hospitals

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

Special Lecture: Predicting the EXCEL Results from the SYNTAX Score II

欧洲学会发布更新后的CAD血运重建指南

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

European Societies Release Updated Revascularization Guidelines for CAD

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Meta Análisis: El Sexo del Paciente Influye en la Respuesta del Abordaje Invasivo Rutinario en el Manejo de Cuadros de SCASEST

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Readmissions Higher with PCI vs CABG for Left Main Disease

Más Rehospitalizaciones con PCI frente a CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

El Cilostazol Adicional Reduce la Reestenosis en Pacientes de Alto Riesgo que recibieron un SLF

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content